Abstract:Objective To investigate the clinical effect of Entecavir in the treatment of chronic hepatitis B with hepatic steatosis.Methods Eighty patients with chronic hepatitis B and hepatic steatosis admitted to our hospital from February to November in 2017 were aelected as subjects.The patients were equally divided into observation group and control group according to computer randomization.In the observation group,Entecavir was used,and in the control group,Rosuvastatin was adopted.The serum alanine aminotransferase (ALT),hepatitis B virus-DNA,blood lipid index and therapeutic effect were compared between the two groups.Results After treatment,the serum ALT and hepatitis B virus-DNA of patients in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the total cholesterol,triglyceride and low density lipoprotein cholesterol in the observation group were lower than those in the control group,and the high density lipoprotein cholesterol was higher than that in the control group,the differences were statistically significant(P<0.05).The total effectiveness rate of the observation group was higher than that of the control group with a statistical difference (P<0.05).Conclusion The efficacy of Entecavir in the treatment of chronic hepatitis B with hepatic steatosis is very significant,which can improve the blood lipid index,and is worthy of study.
李冉. 恩替卡韦治疗慢性乙型肝炎合并肝脂肪变的临床效果[J]. 中国当代医药, 2019, 26(3): 110-112.
LI Ran. Clinical effect of Entecavir in the treatment of chronic hepatitis B combined with hepatic steatosis. 中国当代医药, 2019, 26(3): 110-112.